Pluri (NASDAQ:PLUR) Issues Earnings Results

Pluri (NASDAQ:PLUR) announced its quarterly earnings data on Tuesday. The company reported ($0.53) EPS for the quarter, Zacks reports. Pluri had a negative return on equity of 917.18% and a negative net margin of 4,184.28%.

Pluri Stock Performance

NASDAQ:PLUR opened at $4.33 on Wednesday. Pluri has a fifty-two week low of $4.07 and a fifty-two week high of $8.48. The company has a current ratio of 5.90, a quick ratio of 5.90 and a debt-to-equity ratio of 4.44. The business’s 50-day simple moving average is $4.51 and its 200-day simple moving average is $4.98.

About Pluri

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.